A phase 2 study to assess BDTX-1535, an oral EGFR inhibitor, in patients with non-small cell lung cancer Meeting Abstract
| Authors: | Patel, J.; Spira, A.; Stevenson, J.; Chen, H.; Baik, C.; Gordon, S.; Henry, J. T.; Ahluwalia, M.; Barve, M.; Huang, C.; Edenfield, J.; Johnson, M.; Eathiraj, S.; Hajdenberg, J.; Yurasov, S.; Yu, H. |
| Abstract Title: | A phase 2 study to assess BDTX-1535, an oral EGFR inhibitor, in patients with non-small cell lung cancer |
| Meeting Title: | 2024 World Conference on Lung Cancer |
| Keywords: | non-small cell lung cancer; egfr inhibitor; bdtx-1535 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 19 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2024 Sep 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S657 |
| Language: | English |
| ACCESSION: | WOS:001337925604164 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2024.09.1242 |
| Notes: | Meeting Abstract: EP.12H.01 -- Source: Wos |
